Far‐Field R‐Wave Reduction with a Novel Lead Design: Experimental and Human Results

Abstract

Animal testing results were reproducible in the acute human test setting. The lead reduced the paced FFRW signal amplitudes significantly, allowing for high atrial sensitivity settings but without sensing the FFRW. A robust P-wave signal could be retained.